Imipramine Antibodies

Santa Cruz Biotechnology features a diverse variety of Imipramine monoclonal antibodies for various research applications. Imipramine Antibodies are optimized for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Imipramine is a tricyclic antidepressant that primarily functions by inhibiting the reuptake of neurotransmitters such as serotonin and norepinephrine, thereby enhancing mood and alleviating symptoms of depression. The role of Imipramine in modulating neurotransmitter levels makes it a significant target for understanding mood disorders and developing therapeutic strategies. The study of Imipramine and its effects on the central nervous system is essential for advancing mental health research. Researchers worldwide rely on Imipramine monoclonal antibodies to investigate neurotransmitter regulation and synaptic function. Understanding Imipramine's mechanism of action continues to provide valuable insights into depression and anxiety treatments. Santa Cruz Biotechnology monoclonal antibodies enable researchers to make meaningful contributions to neuroscience and mental health research.